Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Jenkins

Showing results (731-740 of 799) with videos related to

Pageof 80
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2022
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancerN C Turner, C Swift, B Jenkins, et al.
Oncotarget|December 10, 2015
Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma riskKyle M Walsh, Veryan Codd, Terri Rice, et al.
European Journal of Cancer (Oxford, England : 1990)|January 8, 2013
Description of selected characteristics of familial glioma patients - results from the Gliogene ConsortiumSiegal Sadetzki, Revital Bruchim, Bernice Oberman, et al.
Neuro-Oncology|April 12, 2014
Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancerUlrika Andersson, Carl Wibom, Kristina Cederquist, et al.
The New England Journal of Medicine|October 21, 2005
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancerEdward H Romond, Edith A Perez, John Bryant, et al.
Nature Genetics|October 1, 2013
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complexJohn R Prensner, Matthew K Iyer, Anirban Sahu, et al.
The Journal of Molecular Diagnostics : JMD|February 2, 2025
Clinical Validation of the TruSight Oncology 500 Assay for the Detection and Reporting of Pan-Cancer BiomarkersHussam Al-Kateb, Shannon M Knight, Gopinath Sivasankaran, et al.
Neuro-Oncology|August 10, 2016
Radiogenomics to characterize regional genetic heterogeneity in glioblastomaLeland S Hu, Shuluo Ning, Jennifer M Eschbacher, et al.
Nature Genetics|July 7, 2009
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibilityMargaret Wrensch, Robert B Jenkins, Jeffrey S Chang, et al.
Neuro-Oncology|June 5, 2013
Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesisKyle M Walsh, Terri Rice, Paul A Decker, et al.
Pageof 80

Showing results (731-740 of 799) with videos related to

Sort By:
Pageof 80
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2022
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancerN C Turner, C Swift, B Jenkins, et al.
Oncotarget|December 10, 2015
Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma riskKyle M Walsh, Veryan Codd, Terri Rice, et al.
European Journal of Cancer (Oxford, England : 1990)|January 8, 2013
Description of selected characteristics of familial glioma patients - results from the Gliogene ConsortiumSiegal Sadetzki, Revital Bruchim, Bernice Oberman, et al.
Neuro-Oncology|April 12, 2014
Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancerUlrika Andersson, Carl Wibom, Kristina Cederquist, et al.
The New England Journal of Medicine|October 21, 2005
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancerEdward H Romond, Edith A Perez, John Bryant, et al.
Nature Genetics|October 1, 2013
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complexJohn R Prensner, Matthew K Iyer, Anirban Sahu, et al.
The Journal of Molecular Diagnostics : JMD|February 2, 2025
Clinical Validation of the TruSight Oncology 500 Assay for the Detection and Reporting of Pan-Cancer BiomarkersHussam Al-Kateb, Shannon M Knight, Gopinath Sivasankaran, et al.
Neuro-Oncology|August 10, 2016
Radiogenomics to characterize regional genetic heterogeneity in glioblastomaLeland S Hu, Shuluo Ning, Jennifer M Eschbacher, et al.
Nature Genetics|July 7, 2009
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibilityMargaret Wrensch, Robert B Jenkins, Jeffrey S Chang, et al.
Neuro-Oncology|June 5, 2013
Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesisKyle M Walsh, Terri Rice, Paul A Decker, et al.
Pageof 80